Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14852 | 746 | 36.0 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
856 | 2 | HYPOTHYROIDISM//SUBCLINICAL HYPOTHYROIDISM//HYPERTHYROIDISM | 11613 |
14852 | 1 | MT SINAI BONE PROGRAM//MOL ENDOCRINOL GRP//THYROXINE SUPPRESSIVE THERAPY | 746 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MT SINAI BONE PROGRAM | address | 226656 | 3% | 23% | 24 |
2 | MOL ENDOCRINOL GRP | address | 186521 | 4% | 16% | 28 |
3 | THYROXINE SUPPRESSIVE THERAPY | authKW | 92093 | 0% | 75% | 3 |
4 | SUBCLINICAL HYPERTHYROIDISM | authKW | 74357 | 2% | 14% | 13 |
5 | MOL ENDOCRINOL GRP MED | address | 73673 | 0% | 60% | 3 |
6 | SUPPRESSIVE THERAPY | authKW | 58931 | 1% | 24% | 6 |
7 | L THYROXINE | authKW | 53599 | 2% | 10% | 13 |
8 | HYPERTHYROIDISM | authKW | 53598 | 7% | 2% | 53 |
9 | ACTS SCI | address | 40931 | 0% | 100% | 1 |
10 | ATD THERAPY | authKW | 40931 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 19339 | 61% | 0% | 458 |
2 | Medicine, General & Internal | 484 | 13% | 0% | 98 |
3 | Medicine, Research & Experimental | 114 | 6% | 0% | 43 |
4 | Medical Laboratory Technology | 49 | 2% | 0% | 12 |
5 | Geriatrics & Gerontology | 29 | 1% | 0% | 10 |
6 | Obstetrics & Gynecology | 20 | 2% | 0% | 18 |
7 | Pediatrics | 19 | 3% | 0% | 21 |
8 | Rheumatology | 13 | 1% | 0% | 8 |
9 | Orthopedics | 7 | 1% | 0% | 11 |
10 | Cell Biology | 4 | 3% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MT SINAI BONE PROGRAM | 226656 | 3% | 23% | 24 |
2 | MOL ENDOCRINOL GRP | 186521 | 4% | 16% | 28 |
3 | MOL ENDOCRINOL GRP MED | 73673 | 0% | 60% | 3 |
4 | ACTS SCI | 40931 | 0% | 100% | 1 |
5 | ATENC PRIMARIA LAS CALESAS | 40931 | 0% | 100% | 1 |
6 | BIODINAM HUMAN BODY MOVIMENT | 40931 | 0% | 100% | 1 |
7 | BONE METAB DIS CLIN | 40931 | 0% | 100% | 1 |
8 | CANC CAMPAIGN HISTOL | 40931 | 0% | 100% | 1 |
9 | CHAIR ENDOCRINOL DIABETOL ISOTOPE THER Y | 40931 | 0% | 100% | 1 |
10 | CHEONGWONGUN PUBL HLTH | 40931 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THYROID | 13600 | 5% | 1% | 35 |
2 | CLINICAL ENDOCRINOLOGY | 6662 | 5% | 0% | 35 |
3 | BONE | 5149 | 4% | 0% | 29 |
4 | JOURNAL OF BONE AND MINERAL RESEARCH | 4797 | 4% | 0% | 28 |
5 | CALCIFIED TISSUE INTERNATIONAL | 4460 | 3% | 0% | 23 |
6 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 4157 | 3% | 0% | 23 |
7 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2718 | 5% | 0% | 40 |
8 | ENDOKRYNOLOGIA POLSKA | 2560 | 1% | 1% | 6 |
9 | ACTA ENDOCRINOLOGICA | 2030 | 2% | 0% | 14 |
10 | ACTA MEDICA HUNGARICA | 1975 | 0% | 2% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYROXINE SUPPRESSIVE THERAPY | 92093 | 0% | 75% | 3 | Search THYROXINE+SUPPRESSIVE+THERAPY | Search THYROXINE+SUPPRESSIVE+THERAPY |
2 | SUBCLINICAL HYPERTHYROIDISM | 74357 | 2% | 14% | 13 | Search SUBCLINICAL+HYPERTHYROIDISM | Search SUBCLINICAL+HYPERTHYROIDISM |
3 | SUPPRESSIVE THERAPY | 58931 | 1% | 24% | 6 | Search SUPPRESSIVE+THERAPY | Search SUPPRESSIVE+THERAPY |
4 | L THYROXINE | 53599 | 2% | 10% | 13 | Search L+THYROXINE | Search L+THYROXINE |
5 | HYPERTHYROIDISM | 53598 | 7% | 2% | 53 | Search HYPERTHYROIDISM | Search HYPERTHYROIDISM |
6 | ATD THERAPY | 40931 | 0% | 100% | 1 | Search ATD+THERAPY | Search ATD+THERAPY |
7 | BIOCHEMICAL BOND MARKERS | 40931 | 0% | 100% | 1 | Search BIOCHEMICAL+BOND+MARKERS | Search BIOCHEMICAL+BOND+MARKERS |
8 | BMD DECREASING | 40931 | 0% | 100% | 1 | Search BMD+DECREASING | Search BMD+DECREASING |
9 | BON RESORPTION MARKERS | 40931 | 0% | 100% | 1 | Search BON+RESORPTION+MARKERS | Search BON+RESORPTION+MARKERS |
10 | BONE AND BONES PHYSIOLOGY | 40931 | 0% | 100% | 1 | Search BONE+AND+BONES+PHYSIOLOGY | Search BONE+AND+BONES+PHYSIOLOGY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WEXLER, JA , SHARRETTS, J , (2007) THYROID AND BONE.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 36. ISSUE 3. P. 673-+ | 130 | 78% | 21 |
2 | BASSETT, JHD , WILLIAMS, GR , (2016) ROLE OF THYROID HORMONES IN SKELETAL DEVELOPMENT AND BONE MAINTENANCE.ENDOCRINE REVIEWS. VOL. 37. ISSUE 2. P. 135 -187 | 179 | 37% | 3 |
3 | GORKA, J , TAYLOR-GJEVRE, R , ARNASON, T , (2013) METABOLIC AND CLINICAL CONSEQUENCES OF HYPERTHYROIDISM ON BONE DENSITY.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. VOL. . ISSUE . P. - | 77 | 83% | 12 |
4 | REDDY, PA , HARINARAYAN, CV , SACHAN, A , SURESH, V , RAJAGOPAL, G , (2012) BONE DISEASE IN THYROTOXICOSIS.INDIAN JOURNAL OF MEDICAL RESEARCH. VOL. 135. ISSUE 3. P. 277 -286 | 75 | 84% | 5 |
5 | WILLIAMS, GR , BASSETT, JHD , NICHOLLS, JJ , BRASSILL, MJ , (2012) THE SKELETAL CONSEQUENCES OF THYROTOXICOSIS.JOURNAL OF ENDOCRINOLOGY. VOL. 213. ISSUE 3. P. 209 -221 | 75 | 68% | 31 |
6 | SCHNEIDER, R , REINERS, C , (2003) THE EFFECT OF LEVOTHYROXINE THERAPY ON BONE MINERAL DENSITY: A SYSTEMATIC REVIEW OF THE LITERATURE.EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. VOL. 111. ISSUE 8. P. 455-470 | 65 | 88% | 22 |
7 | GOGAKOS, AI , BASSETT, JHD , WILLIAMS, GR , (2010) THYROID AND BONE.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. VOL. 503. ISSUE 1. P. 129 -136 | 59 | 65% | 56 |
8 | LAKATOS, P , (2003) THYROID HORMONES: BENEFICIAL OR DELETERIOUS FOR BONE?.CALCIFIED TISSUE INTERNATIONAL. VOL. 73. ISSUE 3. P. 205 -209 | 56 | 92% | 34 |
9 | MURPHY, E , WILLIAMS, GR , (2004) THE THYROID AND THE SKELETON.CLINICAL ENDOCRINOLOGY. VOL. 61. ISSUE 3. P. 285-298 | 66 | 64% | 74 |
10 | HARVEY, CB , O'SHEA, PJ , SCOTT, AJ , ROBSON, H , SIEBLER, T , SHALET, SM , SMARUT, J , CHASSANDE, O , WILLIAMS, GR , (2002) MOLECULAR MECHANISMS OF THYROID HORMONE EFFECTS ON BONE GROWTH AND FUNCTION.MOLECULAR GENETICS AND METABOLISM. VOL. 75. ISSUE 1. P. 17 -30 | 68 | 61% | 46 |
Classes with closest relation at Level 1 |